Free DAPT Score Calculator
Select age and risk factors to calculate the DAPT score
Check all factors that apply to the patient
Assessing Ischemia and Bleeding Risks with the DAPT Score Calculator
The DAPT Score Calculator (Dual Antiplatelet Therapy Score) is a clinical tool designed to evaluate the balance between ischemic protection and bleeding hazard in patients who have completed one year of dual antiplatelet therapy after percutaneous coronary intervention (PCI). By quantifying these competing risks, the DAPT score helps clinicians decide whether to continue or discontinue dual antiplatelet treatment. This article explains the scoring system, its derivation, and how to apply it in practice.
Disclaimer: This calculator is intended for informational and educational purposes only and does not replace individual clinical judgment or professional medical advice.
Understanding Dual Antiplatelet Therapy
Platelets are key blood components responsible for clot formation to stop bleeding. In patients with coronary artery disease, especially after stent implantation, abnormal platelet activity can lead to stent thrombosis and myocardial infarction. Antiplatelet drugs work by preventing platelets from aggregating. Dual antiplatelet therapy (DAPT) combines aspirin with a P2Y12 inhibitor (e.g., clopidogrel, prasugrel, ticagrelor) and is commonly prescribed after a heart attack, after coronary stent placement, or following coronary artery bypass graft surgery (CABG) to protect the heart.
What Is the DAPT Score?
The DAPT score was developed from the large-scale DAPT trial, which included 11,648 randomized patients. Its purpose is to help identify the optimal duration of antiplatelet therapy after PCI with stents. For patients who have already tolerated one year of DAPT without a major ischemic or bleeding event, extending therapy reduces the risk of stent thrombosis and recurrent MI but increases the chance of bleeding. The DAPT score provides a structured way to weigh these outcomes.
The score evaluates nine clinical factors:
- Age of the patient (age contributes points that are subtracted, as detailed below)
- Presence of diabetes mellitus
- Prior PCI or myocardial infarction
- Myocardial infarction at presentation
- Stent diameter less than 3 mm
- Vein graft stent intervention
- History of congestive heart failure (CHF) or left ventricular ejection fraction (LVEF) lower than 30%
- Paclitaxel-eluting stent implantation
- Current or former cigarette smoking
Most factors award 1 point when present. However, CHF/LVEF lower than 30% and vein graft stent intervention each contribute 2 points. The age component follows a separate schedule:
| Age Category | Points |
|---|---|
| 75 years or older | –2 |
| 65 to 74 years | –1 |
| Under 65 years | 0 |
The total DAPT score can range from –2 to 10.
Interpreting the DAPT Score
- Score (high score): The patient is likely to benefit from continuing DAPT beyond one year, as the ischemic risk reduction outweighs the bleeding risk.
- Score (low score): Aspirin monotherapy is probably more favorable; prolonged DAPT would expose the patient to excessive bleeding risk without sufficient ischemic benefit.
How to Use the DAPT Score Calculator
Using the DAPT calculator is straightforward:
- Select the patient’s age to set the age‑based point deduction.
- Answer each of the nine dichotomous (yes/no) questions corresponding to the clinical factors listed above.
- The tool automatically computes the final score and displays the interpretation.
This calculator supports bleeding risk assessment and antiplatelet therapy duration decision‑making in the context of PCI stent management. By inputting readily available clinical data, you can quickly obtain an evidence‑based estimate to guide discussions with patients.
The DAPT score is a validated, widely used instrument that aids clinicians in personalizing antiplatelet therapy after PCI, balancing the twin goals of preventing ischemic events and minimizing bleeding complications.
FAQ
1. What is the DAPT score used for?
The DAPT score (Dual Antiplatelet Therapy Score) helps clinicians decide whether a patient who has completed one year of dual antiplatelet therapy after PCI should continue or stop the treatment. It estimates the trade-off between ischemic protection and bleeding risk by scoring nine clinical factors and age.
2. How does age affect the DAPT score?
Age is a key component of the DAPT score. Patients 75 years or older receive –2 points, those aged 65 to 74 receive –1 point, and those under 65 receive 0 points. Older age thus lowers the total score, favoring de-escalation to aspirin alone.
3. What does a high DAPT score (2 or higher) mean?
A high score (2 or higher) suggests that the patient is more likely to benefit from prolonged dual antiplatelet therapy beyond one year because the reduction in ischemic events outweighs the increased bleeding risk. Continued DAPT is usually recommended for high‑score patients.
4. What factors are included in the DAPT score?
The DAPT score includes nine factors: age (with a point deduction), diabetes, prior PCI or MI, MI at presentation, stent diameter smaller than 3 mm, vein graft stent, CHF or LVEF lower than 30%, paclitaxel-eluting stent, and cigarette smoking. Most factors give 1 point; CHF/LVEF lower than 30% and vein graft stent give 2 points.
5. Can the DAPT calculator replace a doctor's judgment?
No, the DAPT calculator is a decision‑support tool meant to complement, not replace, clinical assessment. Treatment decisions should always consider the full clinical picture, patient preferences, and professional medical advice.
How to Use
- Select the patient's age group to determine the baseline score component.
- Check all the clinical risk factors that apply to the patient based on their medical history.
- Review the total DAPT score and interpretation to help guide dual antiplatelet therapy duration decisions.